摘要
现有研究已证实,高血压是慢性心力衰竭的一个主要危险因素,单纯高血压和伴左室肥厚分别属心力衰竭发展的A、B阶段,早期和积极控制血压是预防心力衰竭的很有前景的措施。血管紧张素转换酶抑制剂(ACEI)、血管紧张素受体阻滞剂(ARB)或利尿剂及其β-受体阻滞剂的联合应用能很好地控制高血压,有效减少因高血压所致心力衰竭及其导致的并发症和病死率。
Studies have shown that hypertension is one of the major risk factors for chronic heart failure. Hypertension without and with complicating left ventricular hypertrophy corresponds respectively to stages A and B in the progression of heart failure. Early and active control of blood pressure is promising for prevention of heart failure. Angiotensin-converting enzyme inhibitor (ACEI) or diuretics in combination with beta-blocker could provide favorable control of blood pressure, and may effectively reduce the comobordity and mortality of heart failure due to hypertension.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2011年第8期593-594,共2页
Chinese Journal of Practical Internal Medicine
关键词
高血压
心力衰竭
药物治疗
hypertention
heart failure
drug therapy